BR0309611A - ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares. - Google Patents

ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares.

Info

Publication number
BR0309611A
BR0309611A BR0309611-4A BR0309611A BR0309611A BR 0309611 A BR0309611 A BR 0309611A BR 0309611 A BR0309611 A BR 0309611A BR 0309611 A BR0309611 A BR 0309611A
Authority
BR
Brazil
Prior art keywords
disorders
schizophrenia
affective
treatment
substituted
Prior art date
Application number
BR0309611-4A
Other languages
English (en)
Inventor
Kurt Lingenhoehl
Yves Auberson
Alyson Fox
Hans Ch Neijt
Hans O Kalkman
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0209889A external-priority patent/GB0209889D0/en
Priority claimed from GB0209887A external-priority patent/GB0209887D0/en
Priority claimed from GB0209886A external-priority patent/GB0209886D0/en
Priority claimed from GB0210371A external-priority patent/GB0210371D0/en
Priority claimed from GB0212760A external-priority patent/GB0212760D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0309611A publication Critical patent/BR0309611A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"áCIDOS AMINOALCANOFOSFÈNICOS SUBSTITUìDOS PARA O TRATAMENTO DA DOR NEUROPáTICA, DOS DISTúRBIOS AFETIVOS E DA ATENçãO, DA ESQUIZOFRENIA, DO ZUMBIDO NO OUVIDO, DA MIOPIA E DE OUTROS DISTúRBIOS OCULARES". A presente invenção refere-se ao uso de ácidos aminoalcanofosfónicos substituídos no tratamento da dor neuropática, nos distúrbios afetivos e da atenção, na esquizofrenia, no zumbido do ouvido, na miopia e em outros distúrbios oculares.
BR0309611-4A 2002-04-30 2003-04-29 ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares. BR0309611A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0209889A GB0209889D0 (en) 2002-04-30 2002-04-30 Organic compounds
GB0209887A GB0209887D0 (en) 2002-04-30 2002-04-30 Organic compounds
GB0209886A GB0209886D0 (en) 2002-04-30 2002-04-30 Organic compounds
GB0210371A GB0210371D0 (en) 2002-05-07 2002-05-07 Organic compounds
GB0212760A GB0212760D0 (en) 2002-05-31 2002-05-31 Organic compounds
PCT/EP2003/004466 WO2003092701A2 (en) 2002-04-30 2003-04-29 Substituted aminoalkanephosphonic acids for the treatment of neuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders

Publications (1)

Publication Number Publication Date
BR0309611A true BR0309611A (pt) 2005-02-09

Family

ID=29408096

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309611-4A BR0309611A (pt) 2002-04-30 2003-04-29 ácidos aminoalcanofosfÈnicos substituìdos para o tratamento da dor neuropática, dos distúrbios afetivos e da atenção, da esquizofrenia, do zumbido no ouvido, da miopia e de outros distúrbios oculares.

Country Status (13)

Country Link
US (1) US20060293282A1 (pt)
EP (1) EP1501518A2 (pt)
JP (2) JP2005527600A (pt)
KR (1) KR20040101573A (pt)
CN (1) CN1649599A (pt)
BR (1) BR0309611A (pt)
CA (1) CA2482524A1 (pt)
IL (1) IL164779A0 (pt)
MX (1) MXPA04010816A (pt)
NO (1) NO20045089L (pt)
PL (1) PL371427A1 (pt)
TW (1) TW200403066A (pt)
WO (1) WO2003092701A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0310868D0 (en) * 2003-05-12 2003-06-18 Novartis Ag Organic compounds
GB0324541D0 (en) * 2003-10-21 2003-11-26 Novartis Ag Organic compounds
GB0324542D0 (en) * 2003-10-21 2003-11-26 Novartis Ag Organic compounds
GB0325175D0 (en) * 2003-10-28 2003-12-03 Novartis Ag Organic compounds
GB0325172D0 (en) * 2003-10-28 2003-12-03 Novartis Ag Organic compounds
GB0325390D0 (en) * 2003-10-30 2003-12-03 Novartis Ag Organic compounds
GB0405034D0 (en) * 2004-03-05 2004-04-07 Novartis Ag Organic compounds
ITMI20071492A1 (it) 2007-07-24 2009-01-25 S I I T Srl Servizio Internazi "composizioni per il trattamento e la prevenzione di condizioni di vertigine e acufeni comprendenti citicolina, estratto di ginkgo biloba e flavoni dimerici di ginkgo biloba"

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994467A (en) * 1989-05-31 1991-02-19 Zimmerman Andrew W Treating autism and other developmental disorders in children with NMDA receptor antagonists
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
GB9400680D0 (en) * 1994-01-14 1994-03-09 Sandoz Ltd Improvements in or relating to organic compounds
DE4439492A1 (de) * 1994-10-25 1996-05-02 Schering Ag Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
AU4423496A (en) * 1995-03-14 1996-10-02 Warner-Lambert Company Novel glutamate (ampa/kainate) receptor antagonists: n-substituted fused azacycloalkylquinoxalinediones
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
GB9604400D0 (en) * 1996-03-01 1996-05-01 Pfizer Ltd Compounds useful in therapy
US6191134B1 (en) * 1996-06-05 2001-02-20 Warner-Lambert Company Amide derivatives of substituted quinoxaline 2, 3-diones as glutamate receptor antagonists
CZ141399A3 (cs) * 1996-10-24 1999-07-14 Novartis Ag Substituované aminoalkanfosfonové kyseliny, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
SE508138C2 (sv) * 1996-12-20 1998-08-31 Ericsson Telefon Ab L M Metod och anordning för anslutning av elektrisk komponent till kretskort
GB9802225D0 (en) * 1998-02-02 1998-04-01 Cerebrus Ltd Chemical compounds
US6291479B1 (en) * 1998-12-03 2001-09-18 Alcon Manufacturing, Ltd. Use of NR2B-selective NMDA-receptor antagonists for the treatment of ophthalmic diseases
GB0018272D0 (en) * 2000-07-25 2000-09-13 Vernalis Research Limited Chemical compounds IV
DE10048969A1 (de) * 2000-08-23 2002-03-14 Mueller Schwefe Gerhard Verwendung von Flupirtin zur Tinnitusbehandlung
MXPA03005130A (es) * 2000-12-07 2004-12-06 Neuromolecular Inc Metodos para tratar trastornos neurosiquiatricos con antagonistas del receptor del nmda.

Also Published As

Publication number Publication date
CN1649599A (zh) 2005-08-03
JP2005527600A (ja) 2005-09-15
WO2003092701A2 (en) 2003-11-13
CA2482524A1 (en) 2003-11-13
US20060293282A1 (en) 2006-12-28
KR20040101573A (ko) 2004-12-02
TW200403066A (en) 2004-03-01
JP2009137995A (ja) 2009-06-25
IL164779A0 (en) 2005-12-18
PL371427A1 (en) 2005-06-13
EP1501518A2 (en) 2005-02-02
NO20045089L (no) 2004-11-23
AU2003232224A1 (en) 2003-11-17
WO2003092701A3 (en) 2004-04-08
MXPA04010816A (es) 2005-03-07

Similar Documents

Publication Publication Date Title
DE60117043D1 (de) Behandlung von mukositis
BR0212898A (pt) Método de tratamento de infecções do ouvido médio
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
DE60020613D1 (de) (S,S)-Reboxetin zur Behandlung von Fibromyalgie und anderen somatoformen Störungen
ATE375174T1 (de) Zusammensetzung und verfahren zur pflege von kontaktlinsen
BRPI0407662B8 (pt) derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
ATE322872T1 (de) Skleraprothese zur behandlung der weitsichtigkeit und anderer augenkrankheiten
DE50109156D1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
BR0014905A (pt) Produto de tecido antivìrus e processo para produzir o mesmo
EA200200137A1 (ru) Лечение невротических нарушений
BR0012291A (pt) Fenoxifluorpirimidinas
DE60138385D1 (de) Heilmittel zur behandlung von erkrankungen des sehnervs
DE60231246D1 (de) Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
MXPA04010816A (es) Acidos aminoalcanfosfonicos sustituidos para el tratamiento de dolor neuropatico, trastornos afectivos y de la atencion, esquizofrenia, tinitus, miopia y otros trastornos oculares.
BR0113201A (pt) processo para tratar distúrbios neurodegenerativos da retina e da cabeça do nervo óptico
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
AR026062A1 (es) Tratamiento de desordenes oculares
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários
BR0214060A (pt) Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
ATE448779T1 (de) Methode zur behandlung trockener augen und uveitis
DE69920959D1 (de) Verwendung von riluzol zur behandlung von akustischen traumazuständen
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE239458T1 (de) Verwendung von selegilin zur behandlung von epileptischen erkrankungen

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011.